Jose M. Trevejo - Net Worth and Insider Trading
Jose M. Trevejo Net Worth
The estimated net worth of Jose M. Trevejo is at least $111,244 dollars as of 2024-11-10. Jose M. Trevejo is the CHIEF MEDICAL OFFICER of Tarsus Pharmaceuticals Inc and owns about 2,251 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $111,244. Details can be seen in Jose M. Trevejo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jose M. Trevejo has not made any transactions after 2023-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jose M. Trevejo
Jose M. Trevejo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jose M. Trevejo owns 1 companies in total, including Tarsus Pharmaceuticals Inc (TARS) .
Click here to see the complete history of Jose M. Trevejo’s form 4 insider trades.
Insider Ownership Summary of Jose M. Trevejo
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2023-12-20 | Chief Medical Officer |
Jose M. Trevejo Latest Holdings Summary
Jose M. Trevejo currently owns a total of 1 stock. Jose M. Trevejo owns 2,251 shares of Tarsus Pharmaceuticals Inc (TARS) as of December 20, 2023, with a value of $111,244.
Latest Holdings of Jose M. Trevejo
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2023-12-20 | 2,251 | 49.42 | 111,244 |
Holding Weightings of Jose M. Trevejo
Jose M. Trevejo Form 4 Trading Tracker
According to the SEC Form 4 filings, Jose M. Trevejo has made a total of 5 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the sale of 2,252 shares on December 20, 2023, which brought Jose M. Trevejo around $45,040.
Insider Trading History of Jose M. Trevejo
- 1
Jose M. Trevejo Trading Performance
Jose M. Trevejo Ownership Network
Ownership Network List of Jose M. Trevejo
Ownership Network Relation of Jose M. Trevejo
Jose M. Trevejo Owned Company Details
What does Tarsus Pharmaceuticals Inc do?
Who are the key executives at Tarsus Pharmaceuticals Inc?
Jose M. Trevejo is the Chief Medical Officer of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include See Remarks Jeffrey S Farrow , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .
Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary
Over the past 18 months, Jose M. Trevejo made 2 insider transaction in Tarsus Pharmaceuticals Inc (TARS) with a net sale of 3,856. Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 231,415 shares made by Bobak R. Azamian , a net sale of 11,909 shares made by Aziz Mottiwala , and a net sale of 12,792 shares made by Bryan Wahl .
In summary, during the past 3 months, insiders sold 35,000 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 35,000 shares. During the past 18 months, 322,965 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 312,459 shares.
Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tarsus Pharmaceuticals Inc Insider Transactions
Jose M. Trevejo Mailing Address
Above is the net worth, insider trading, and ownership report for Jose M. Trevejo. You might contact Jose M. Trevejo via mailing address: C/o Tarsus Pharmaceuticals, Inc., 15440 Laguna Canyon Road, Suite 160, Irvine Ca 92618.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
